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Background: The number of children being diagnosed with type 1 diabetes mellitus (T1DM) 
is on the rise and has more than doubled in the past 10 years in Bahrain. Some studies have 
linked low vitamin D levels with an increased risk of diabetes. There are concerns regarding 
the variations in circulating 25(OH)D levels measured by different laboratories and by using 
different analytical techniques.
Objective: The aim of this study was to evaluate the vitamin D levels of newly diagnosed children 
with T1DM using the “gold standard method” with high-pressure liquid chromatography–tandem 
mass spectrometry methods compared to the chemiluminescence micro-particle immunoassay 
(CMIA) used in a hospital laboratory.
Subjects: Eighteen children, aged 6–12 years, who received a confirmed diagnosis of T1DM 
in 2014 were chosen as subjects.
Methods: Serum vitamin D levels were assessed in a hospital, while an extra aliquot of blood col-
lected during routine blood collection after acquiring informed written consents from the subjects, 
and sent to Princess Al-Jawhara Center for Molecular Medicine and Inherited Disorders to be ana-
lyzed by ultra-performance liquid chromatography–tandem mass spectrometry (UPLC-MS/MS).
Results: The mean age of the study group was 9±2 years. The mean total of 25(OH)D levels (D
3
 
and D
2
) assessed by UPLC-MS/MS was 49.7±18.8, whereas the mean total of 25(OH)D levels 
obtained from the CMIA assay was 44.60±13.20. The difference in classification between the 
two methods was found to be statistically significant (P=0.004). A Bland–Altman plot showed a 
poor level of agreement between the two assay methods. The CMIA overestimated insufficient 
values and underestimated deficiency, when compared to UPLC-MS/MS.
Conclusion: There was a statistically significant difference between the two assay methods with 
CMIA overestimating vitamin D insufficiency. Clinicians should be prudent in their assessment 
of a single vitamin D reading, when the gold standard method is not available or feasible.
Keywords: type 1 diabetes, children, vitamin D, Middle East
Introduction
A large number of studies have reported a relationship between vitamin D levels and the 
risk of osteoporosis, diabetes, cancer, multiple sclerosis, and rheumatoid arthritis.1 Some 
studies have also linked low vitamin D levels with an increased risk of diabetes,2–4 while 
other studies have found that children who were regularly supplemented with vitamin D in 
the first year of life had a reduced risk of developing type 1 diabetes mellitus (T1DM).2
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T1DM in children is on the rise worldwide.5 The number 
of children being diagnosed with T1DM is also on the rise in 
Bahrain. The number of those newly diagnosed victims has 
more than doubled in the past 10 years with 25 new cases 
diagnosed per 100,000 population in 2010.6
Vitamin D is often described as a fat-soluble vitamin, but 
it also exhibits hormonal properties in its active form through 
its action via vitamin D receptors found in most tissues in the 
human body.7 More than 90% of the vitamin D requirement 
for most people is believed to come from casual exposure to 
sunlight.8–10 Vitamin D is produced endogenously by the skin 
via photosynthesis using ultraviolet B light, which converts 
7-dehydroxycholesterol to pre-vitamin D
3
.11 It can also be 
obtained from the diet or from a dietary supplement; fatty fish 
and fish liver oils are a good source of the vitamin.12
This research is a substudy of a larger study undertaken 
by the author to explore dietary and health risk factors of 
T1DM in children.13,14 The objective of the larger study was 
to evaluate the association between physiological factors, 
such as vitamin D levels and lifestyle factors (eg, activity 
levels and frequency of sunlight exposure) and diabetes 
prevalence in a small, but representative sample of newly 
diagnosed children. In this regard, the ideal assay method for 
determining serum vitamin D levels in this sample of children 
was subject to considerable debate; hence, this study reports 
on the experience of assaying vitamin D levels using two 
different methods to help inform future practice.
Vitamin D levels are tested as part of the routine blood 
workup for all newly diagnosed children with T1DM admitted 
at the Salmaniya Medical Complex (SMC), the main govern-
mental hospital in Bahrain. Currently, the hospital laboratory 
uses an automated chemiluminescence micro-particle immu-
noassay (CMIA) kit (ARCHITECT; Abbott Laboratories, 
Abbott Park, IL, USA) to test vitamin D levels. Serum 25(OH)
D (25-hydroxy vitamin D), known as calcidiol, is considered 
a good indicator of vitamin D levels.1,15,16 However, concerns 
remain regarding the variations in circulating 25(OH)D levels 
measured by different laboratories and by different analytical 
techniques as highlighted by Binkley et al.17 Some of the com-
monly used alternate assays include radioimmunoassay (RIA), 
enzyme-linked immunosorbent assay, high-performance 
liquid chromatography (HPLC), liquid chromatography 
coupled with mass spectrometry (LC-MS), and automated 
assay using chemiluminescence immunoassay (CLIA).
HPLC is considered as the gold standard assay method 
for the detection of 25(OH)D levels.18 It is a technique that 
requires pumps to pass a pressurized liquid solvent, which 
contains a blood sample mixture through a column filled with 
a solid adsorbent material. The constituents of the sample 
mixture pass through the pumps and interact differently with 
the adsorbent material, thus resulting in varying flow rates 
and the ultimate separation of the components. Following 
HPLC, quantification of vitamin D is made possible by 
UV detection at 264 nm.19 The absorption spectrum is then 
computed as a chromatogram with retention time being 
used as a means to identify the compound.15 This process 
is fully automated and has the ability to separately assay 
vitamins D
2
, D
3
, and D
3
 metabolites.19 CLIA, on the other 
hand, involves the attachment of highly specific proteins to 
magnets in a competitive binding protein assay reaction, 
which causes the chemical substrate to produce light that is 
then detected and measured.20A blood sample is combined 
with anti-human vitamin D coated micro-particles, which 
causes the vitamin D to disassociate from its binding protein, 
thus allowing it to bind to these micro-particles. A conjugate 
is then added, which produces a chemiluminescent reaction 
with the antibodies bound to these micro-particles, produc-
ing light that can be measured.21 Although studies have 
compared commercially available assays using CLIA or RIA 
methods to HPLC,17,22 no studies, to the best of the author’s 
knowledge, have assessed vitamin D levels of children with 
T1DM comparing these two methods. In light of the grow-
ing evidence of the importance of vitamin D in relation to 
diabetes, the reliability of 25(OH)D measurements should be 
evaluated, as these results will ultimately inform the manage-
ment of those who are found to be insufficient. The aim of 
this study was to investigate whether there is a significant 
difference in vitamin D levels in newly diagnosed children 
with T1DM as measured by the gold standard method using 
high-performance liquid chromatography tandem mass 
spectrometry when compared to the CLIA method currently 
used in the SMC.
Methods
Recruitment and data collection took place from mid-January 
till the end of March; months considered to be cooler although 
it should be noted that Bahrain enjoys sunlight all year around 
with a monthly average of 7 hours of sunlight over the year.23 
The inclusion criteria for study subjects were as follows:
•	 Newly diagnosed children aged 6–12 years with a 
confirmed diagnosis of T1DM
•	 Informed, written consent from parents or legal guardian
•	 Patients were being followed up at the Pediatric Endocrine 
Unit in the SMC hospital.
The study subjects were 18 (nine males and nine females) 
children newly diagnosed with T1DM, aged 6–12 years, 
and admitted to the SMC. This study was approved by 
the Salmaniya Medical Complex Health Research Ethics 
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Committee. Informed, written consent was obtained from 
the parents or legal guardian and all children were followed 
up at the Pediatric Endocrine Unit in the SMC. Vitamin D 
levels were measured as part of the routine blood collection 
and analyzed by CMIA at the SMC laboratory; however, 
an extra blood sample was collected from the study sub-
jects and sent to Princess Al-Jawhara Center for Molecular 
Medicine and Inherited Disorders in Bahrain to be analyzed 
by ultra-Performance liquid chromatography tandem mass 
spectrometry (UPLC-MS/MS).
SPSS Statistical package Version 22 was used for data 
entry and analysis. A paired sample t-test was performed 
as a measure of assay association. Chi-squared tests were 
used to compare the sufficiency classifications of the group 
between the two methods and Bland–Altman analysis 
(constructed using MedCal software Version 14.10.2) was 
used to measure assay agreement. A P-value ,0.05 was 
considered as significant.
Results
The mean age of the study group was 9±2 years with a mean 
body mass index (BMI) percentile of 54.3±36.9 as shown in 
Table 1. The mean total 25(OH)D levels (D
3
 and D
2
) assessed 
by UPLC-MS/MS was 49.7±18.8, whereas the mean total 
25(OH)D levels assessed by CMIA assay was 44.60±13.20 
(see Table 2). The mean total 25(OH)D levels for males was 
58.0±14.2 and for females was 41.3±19.7, which is a differ-
ence approaching significance (P=0.056). According to the 
cut off values set by the authors to define hypovitaminosis, 
22% of children analyzed using the UPLC-MS/MS method 
were classified as being deficient with a serum vitamin D 
level below 30 nmol/L, 28% had insufficient vitamin D 
levels between 30 and 50 nmol/L and 50% of the children 
had optimal levels of vitamin D, which is .50 nmol/L as 
shown in Figure 1. Analysis using CMIA, on the other hand, 
classified 11% of the children as being deficient, 61% as 
being insufficient, and only 28% as having optimal levels of 
vitamin D. The difference in classification between the two 
methods was found to be statistically significant (P=0.004); 
there was also a statistically significant difference in the 
mean vitamin D measurements between the two assays 
(P=0.048).
A Bland–Altman plot, which shows the discrepancies 
between results for individual samples, was used to reveal the 
differences between the two methods. The Bland–Altman plot 
with linear regression analysis with 95% confidence limits 
is presented in Figure 2. It clearly shows that the CMIA is 
biased when compared to the UPLC-MS/MS method. CMIA 
overestimated insufficient values and underestimated defi-
ciency, when compared to UPLC-MS/MS.
Discussion
Variations in circulating 25(OH)D levels between assay 
methods and interlaboratory measurements can poten-
tially confound the diagnosis of hypovitaminosis D.17 
There is currently no consensus on the optimal reference 
to classify moderate to severe insufficiency among clini-
cians and this may be, in part, due to an inter-method 
bias.22,24 Furthermore, there is currently no consensus on 
the vitamin D intake required for optimal health, despite 
a substantial number of published studies, which aim to 
determine what constitutes an adequate intake. Many of 
these studies have unfortunately had mixed outcomes 
and were lacking in the robust designs needed to develop 
dietary guidelines.15
The USA Institute of Medicine’s (IOM) most recent 
recommendation is a recommended dietary intake of 600 IU 
of vitamin D in children, who are 1 year old and more in 
order to achieve a 25(OH)D level of 50 nmol/L which, 
according to IOM, meets the requirements of 97.5% of 
the healthy population.16 However, there has been recent 
controversy regarding the accuracy of this estimation.25,26 
Indeed, Veugelers and Ekwaru argue that over 8,000 IU of 
vitamin D is a more accurate estimation of the needs of 97.5% 
of a healthy population in order to achieve a serum value of 
50 nmol or above.25 Furthermore, the study by Heaney et al 
corroborated these findings and put forth the argument that 
a total intake of close to 7,000 IU per day is a more accurate 
Table 1 Baseline characteristics of sample children with type 1 
diabetes (n=18) recruited to a study of vitamin D analysis
    Mean (SD) Range
age (years) 9.00 (2) 6.00–12.00
BMi (percentile) 54.28 (36.86) ,1.0–98.4
Waist circumference (cm) 68.50 (12.70) 49.5–94.5
MUac (mm) 18.00 (6.90) 10.00–40.00
Abbreviations: SD, standard deviation; BMi, body mass index; MUac, mid-upper 
arm circumference.
Table 2 Mean 25-hydroxyvitamin D (25(Oh)D) values as 
assessed by two methods for children diagnosed with type 1 
diabetes mellitus (T1DM) (n=18)
     Mean (SD) Range P-value
VitaminD3 + D2 UPlc-MS/MS 49.65 (18.75) 18.10–78.30 0.048
Vitamin D cMia 44.60 (13.20) 22.70–67.30
Vitamin D3 UPlc-MS/MS 49.10 (19.00) 16.80–78.3
Vitamin D2 UPlc-MS/MS 2.00 (2.00) 0.00–5.00
Abbreviations: UPlc-MS/MS, ultra-performance liquid chromatography–tandem 
mass spectrometry; cMia, chemiluminescent micro-particle immunoassay; 
SD, standard deviation.
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50%
22%
28%
11%
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30 to <50 nmol/L
(insufficient)
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61%
28%
Figure 1 The percentage of children with T1DM classified as being deficient, insufficient, or having optimal serum levels of vitamin D using UPLC-MS/MS (n=18) and clia 
(n=18) assay methods.
Notes: The difference in classification between the two methods was significant; P=0.004 (chi-squared).
Abbreviations: T1DM, type 1 diabetes mellitus; UPlc-MS/MS, ultra-high performance liquid chromatography–tandem mass spectrometry; clia, chemiluminescence 
immunoassay.
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recommendation than the 600 IU intake currently suggested 
by the IOM.
There are a limited number of studies that have looked into 
the vitamin D levels of children in the Middle Eastern region27–30 
and research on the vitamin D status of children with T1DM in 
the Middle East is even scarcer. In fact, only one study by Bener 
et al31 exclusively looked at children with T1DM, concluding 
that vitamin D deficiency was significantly higher in children 
with T1DM, when compared to healthy controls.
Several studies that have compared commercially avail-
able assays using CLIA or RIA methods to HPLC have found 
low inter-assay agreement.22,32,33 Farrell et al33 describe the 
variability in results of vitamin D in “state of the art” auto-
mated immuno-assays including the ARCHITECT (Abbott 
Laboratories) (currently used in our facility), which showed 
the greatest deviation of all assays when compared to the 
LC-MS/MS. Detection of 25(OH)D levels appears to be 
largely method-dependent.33,34 Wallace et al in their review 
of the measurement procedures and limitations of vitamin 
D assays, conclude that the precision of immunoassays as 
well as HPLC and LC-MS/MS were comparable in detect-
ing severe vitamin D deficiency, nonetheless the authors 
highlighted the need for a standard reference method.35
Putting the results of this study into clinical context, we 
can conclude that (assuming any newly diagnosed child with 
T1DM with a 25(OH)D level of ,50 nmol/L was indicated 
for supplementation) 50% of the children would require 
supplementation according to UPLC-MS/MS measurements, 
when compared to 72% of children according to CMIA 
measurements. Other studies19 cite an approximate 20% 
misclassification rate between samples assessed using CLIA 
and LC-MS/MS with 57% and 41%, respectively, being clas-
sified as deficient using a cut-point of 50 nmol/L.
However, deciding on which assay method to use depends 
on balancing out many factors. First, laboratories that test on 
a frequent basis and require a higher output may benefit more 
from a commercially available kit.20 However, it is important 
to take into consideration that inexperienced users of such 
commercial kits may introduce more assay variability.17 
Furthermore, one must also take into consideration the 
commercial assays that discriminate between D
2
 and D
3
, 
which may result in an underestimation of vitamin D levels. 
Second, the cost of the assays is another factor to consider; 
the cost of running vitamin D assays using HPLC method is 
currently three times the cost of the CMIA method used in 
the hospital laboratory.
Since vitamin D levels are implicated in a number of 
disorders, the wider implication of inaccurate readings in the 
management of hypovitaminosis D is not limited to children 
with T1DM. Hence, in light of the multifactorial issues 
surrounding diagnosis and treatment of  hypovitaminosis D, 
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Figure 2 Bland–altman plot showing a concentration dependent difference between 
the UPlc-MS/MS and the clia method.
Note: Linear regression analysis and 95% confidence intervals are shown.
Abbreviations: UPlc-MS/MS, ultra-high performance liquid chromatography–tandem 
mass spectrometry; clia, chemiluminescence immunoassay; SD, standard deviation.
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the authors of this paper support the recommendation 
that clinicians be prudent in their assessment of 25(OH)
D measurements as variations exist between the assay 
methods.17,19
Conclusion
There was a statistically significant difference between the 
two assay methods with CMIA overestimating vitamin D 
insufficiency. Clinicians should take care in their assessment 
of a single vitamin D reading in the treatment of hypovi-
taminosis D when HPLC, which is considered as the gold 
standard assay method, is not available or feasible to use.
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